Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients.
J Clin Oncol
; 18(3): 659-67, 2000 Feb.
Article
en En
| MEDLINE
| ID: mdl-10653882
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Camptotecina
/
Neoplasias
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2000
Tipo del documento:
Article